Segment Reporting (Tables)

12 Months Ended

Dec. 31, 2023

Segment Reporting [Abstract]

Schedule of Segments

The following table presents certain information regarding the Company’s segments as of and for the years ended December 31, 2023 and December 31, 2022 (in thousands, including amount in notes):

2023

	CVD Equipment			SDC		CVD Materials			Corporate			Eliminations			Consolidated
Assets	$	31,401		$	3,468	$	211		$	-		$	(55	)	$	35,025
Revenue	$	16,334		$	7,139	$	1,184		$	-		$	(548	)	$	24,109
Operating (loss) income(1)		(2,129	)		1,677		(193	)		(4,118	)		(118	)		(4,881	)
Pretax (loss) income (1)		(2,070	)		1,677		(141	)		(3,542	)		(118	)		(4,194	)
Depreciation and amortization	$	620		$	49	$	123		$	-		$	-		$	792
Purchases of property, plant & equipment	$	404		$	14	$	-		$	-		$	-		$	418

2022

	CVD Equipment			SDC		CVD Materials		Corporate			Eliminations			Consolidated
Assets	$	31,622		$	4,149	$	2,099	$	-		$	42		$	37,912
Revenue	$	16,674		$	6,541	$	3,171	$	-		$	(573	)	$	25,813
Operating (loss) income		(1,430	)		1,546		1,050		(2,989	)		-			(1,823	)
Pretax (loss) income (2)		(156	)		1,849		1,076		(2,989	)		-			(220	)
Depreciation and amortization	$	652		$	49	$	166	$	-		$	-		$	867
Purchases of property, plant & equipment (3)	$	653		$	3	$	3	$	-		$	-		$	-

(1)	CVD Materials segment includes loss on sale of Tantaline of $0.2 million and an impairment charge related to MesoScribe fixed assets of $0.1 million.
(2)	Includes other income related to ERCs of $1,103, $303 and $123 for the CVD, SDC and Materials segments, respectively.
(3)	Include $0.4 million of purchased equipment financed with a loan